COVID-KOSHA
Home
Help
(current)
Comment
!
Note: Language translations may be imperfect
A model anti-pandemic portal for scientists & public
;
High priority articles (R1, Most articles most likely to be relevant):
Second priority articles (R2, Moderate portion of articles likely to be relevant):
Other articles (R3, Lesser portion of articles likely to be relevant):
Auto Summaries -
Immunology
Last updated: 2024 Oct 18
Total hit(s): 28039
S.No.
PMID
Ascending order
Descending order
Title
Ascending order
Descending order
Auto Summary
Ascending order
Descending order
Journal Name
Ascending order
Descending order
Publish Date
Ascending order
Descending order
Impact Factor
Ascending order
Descending order
Citations
Ascending order
Descending order
1
39393042
Comment on: "COVID-19 vaccine hesitancy among the Chinese elderly: A multi-stakeholder qualitative study".
N/A
Hum Vaccin Immunother
2024 Dec 31
4.7
1
2
38787317
Regarding "Reply to the enhancing the accuracy of seroprevalence studies: Reassessing pertussis infection rates in Eastern China during the COVID-19 pandemic".
N/A
Hum Vaccin Immunother
2024 Dec 31
4.7
1
3
38709953
Reply to the enhancing the accuracy of seroprevalence studies: Reassessing pertussis infection rates in Eastern China during the COVID-19 pandemic.
N/A
Hum Vaccin Immunother
2024 Dec 31
4.7
1
4
38501434
Politics and confidence toward the COVID-19 vaccination: Points to be considered.
N/A
Hum Vaccin Immunother
2024 Dec 31
4.7
1
5
39312724
Comment on "Effectiveness of homologous or heterologous immunization regimens against SARS-CoV-2 after two doses of inactivated COVID-19 vaccine: A systematic review and meta-analysis".
N/A
Hum Vaccin Immunother
2024 Dec 31
4.7
1
6
38593300
Immunogenicity of COVID-19 vaccines in patients with cirrhosis: Expected advantage for additional dose of vaccine.
N/A
Hum Vaccin Immunother
2024 Dec 31
4.7
1
7
38626299
Enhancing the accuracy of seroprevalence studies: Reassessing pertussis infection rates in eastern China during the COVID-19 pandemic.
N/A
Hum Vaccin Immunother
2024 Dec 31
4.7
1
8
38353267
Ethical concerns regarding heterologous COVID-19 vaccine administration.
N/A
Hum Vaccin Immunother
2024 Dec 31
4.7
1
9
38696268
Deceptive tactics: Misappropriation of scientific literature by 'Gazeta do Povo' in undermining COVID-19 vaccination efforts.
N/A
Hum Vaccin Immunother
2024 Dec 31
4.7
1
10
39352690
Correction to "Clinical predictors of donor antibody titre and correlation with recipient antibody response in a COVID-19 convalescent plasma clinical trial".
N/A
J Intern Med
2024 Nov
6.871
1
11
39310378
COVID-19 vaccine uptake among young adults and influence of asthma.
N/A
J Allergy Clin Immunol Glob
2024 Nov
1
12
39356998
Equitable Uptake of Life-Saving COVID-19 Primary Vaccine Series in Community Health Centers.
N/A
Am J Public Health
2024 Nov
4.21
1
13
39385397
COVID-19 Vaccination Rates and Vaccine Hesitancy in Pregnant Women in Seven Low- and Middle-Income Countries Through May 2023: An Observational Study From the Global Network.
N/A
BJOG
2024 Oct 9
4.51
1
14
39348533
Reply to Fitzgerald: COVID-19 vaccine mandates and voluntary vaccination behavior.
N/A
Proc Natl Acad Sci U S A
2024 Oct 8
9.35
1
15
39348537
US states that mandated COVID-19 vaccination see higher, not lower, take-up of COVID-19 boosters and flu vaccines.
N/A
Proc Natl Acad Sci U S A
2024 Oct 8
9.35
1
16
39389075
12-month persistence of immune responses to self-amplifying mRNA COVID-19 vaccines: ARCT-154 versus BNT162b2 vaccine.
N/A
Lancet Infect Dis
2024 Oct 7
21.77
1
17
39389072
Revisiting MERS-CoV vaccination in the SARS-CoV-2 era.
N/A
Lancet Infect Dis
2024 Oct 7
21.77
1
18
39191180
Editorial: ML-driven vaccine against COVID-19: Developmental challenges and foresight.
N/A
Vaccine
2024 Oct 3
3.31
1
19
39360743
Understanding Mechanism to Improve Willingness for COVID-19 Vaccine Uptake Among Young Chinese Adults: Evidence From Protection Motivation Theory.
N/A
Asia Pac J Public Health
2024 Oct 3
1.85
1
20
39374197
Health Care Access and COVID-19 Vaccination in the United States: Comment.
N/A
Med Care
2024 Oct 2
4.2
1
21
39374180
Reply to Comments on Health Care Access and COVID-19 Vaccination in the United States.
N/A
Med Care
2024 Oct 2
4.2
1
22
39396886
Corrigendum to "A comparison of four self-controlled study designs in an analysis of COVID-19 vaccines and myocarditis using five European databases" [Vaccine 42 (12) (2024) 3039-3048].
N/A
Vaccine
2024 Oct 12
3.31
1
23
39392694
Correction: BNT162b2 versus mRNA-1273 Third Dose COVID-19 Vaccine in Patients with CKD and Maintenance Dialysis Patients.
N/A
Clin J Am Soc Nephrol
2024 Oct 11
6.01
1
24
39390426
Correction: COVID-19 vaccination side effects among the child age group: a large cross-sectional online based survey in Saudi Arabia.
N/A
BMC Infect Dis
2024 Oct 10
2.58
1
25
39387988
Bridging the Gap: Delphi Consensus Statements for SARS-CoV-2 Vaccination in Immunocompromised Patients.
N/A
Infect Dis Ther
2024 Oct 10
3.95
1